Figure 3
Figure 3. Cumulative incidence of posttransplant relapse. (A) Overall cohort. (B) After fludarabine-TBI-cyclophosphamide. (C) After busulfan-cyclophosphamide and ATG.

Cumulative incidence of posttransplant relapse. (A) Overall cohort. (B) After fludarabine-TBI-cyclophosphamide. (C) After busulfan-cyclophosphamide and ATG.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal